NASDAQ:CDLX Cardlytics (CDLX) Stock Price, News & Analysis $3.83 -0.09 (-2.30%) (As of 10/23/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends About Cardlytics Stock (NASDAQ:CDLX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cardlytics alerts:Sign Up Key Stats Today's Range$3.69▼$4.0050-Day Range$3.06▼$4.0852-Week Range$2.89▼$20.52Volume1.02 million shsAverage Volume1.25 million shsMarket Capitalization$186.84 millionP/E RatioN/ADividend YieldN/APrice Target$6.92Consensus RatingReduce Company OverviewCardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.Read More… Watch this before it gets removed (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Cardlytics Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks77th Percentile Overall ScoreCDLX MarketRank™: Cardlytics scored higher than 77% of companies evaluated by MarketBeat, and ranked 83rd out of 333 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.9 / 5Analyst RatingReduce Consensus RatingCardlytics has received a consensus rating of Reduce. The company's average rating score is 1.86, and is based on no buy ratings, 6 hold ratings, and 1 sell rating.Amount of Analyst CoverageCardlytics has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Cardlytics' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Earnings GrowthEarnings for Cardlytics are expected to remain at ($1.72) per share in the coming year.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cardlytics is -1.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cardlytics is -1.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCardlytics has a P/B Ratio of 1.12. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Cardlytics' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted16.99% of the outstanding shares of Cardlytics have been sold short.Short Interest Ratio / Days to CoverCardlytics has a short interest ratio ("days to cover") of 7.1.Change versus previous monthShort interest in Cardlytics has recently increased by 0.36%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCardlytics does not currently pay a dividend.Dividend GrowthCardlytics does not have a long track record of dividend growth. Sustainability and ESG2.8 / 5Environmental Score-0.67 Percentage of Shares Shorted16.99% of the outstanding shares of Cardlytics have been sold short.Short Interest Ratio / Days to CoverCardlytics has a short interest ratio ("days to cover") of 7.1.Change versus previous monthShort interest in Cardlytics has recently increased by 0.36%, indicating that investor sentiment is decreasing. News and Social Media1.7 / 5News Sentiment0.10 News SentimentCardlytics has a news sentiment score of 0.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.41 average news sentiment score of Business Services companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Cardlytics this week, compared to 3 articles on an average week.MarketBeat Follows3 people have added Cardlytics to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Cardlytics insiders have sold 82.37% more of their company's stock than they have bought. Specifically, they have bought $143,200.00 in company stock and sold $261,149.00 in company stock.Percentage Held by InsidersOnly 4.40% of the stock of Cardlytics is held by insiders.Percentage Held by Institutions68.10% of the stock of Cardlytics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Cardlytics' insider trading history. Receive CDLX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cardlytics and its competitors with MarketBeat's FREE daily newsletter. Email Address CDLX Stock News HeadlinesInsider Selling: Cardlytics, Inc. (NASDAQ:CDLX) Insider Sells 5,936 Shares of StockOctober 4, 2024 | insidertrades.comCardlytics Announces Timing of Its Third Quarter 2024 Earnings ReleaseOctober 23 at 4:01 PM | globenewswire.comWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonOctober 24, 2024 | Porter & Company (Ad)Evercore ISI Begins Coverage on Cardlytics (NASDAQ:CDLX)October 14, 2024 | americanbankingnews.comEvercore ISI Group Initiates Coverage of Cardlytics (CDLX) with In-Line RecommendationOctober 12, 2024 | msn.comIs Cardlytics, Inc. (CDLX) the Worst Advertising Stock to Buy According to Short Sellers?September 29, 2024 | msn.comIs Cardlytics, Inc. (CDLX) the Worst Marketing Stock to Buy?September 28, 2024 | msn.comCardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens BermanSeptember 26, 2024 | globenewswire.comSee More Headlines CDLX Stock Analysis - Frequently Asked Questions How have CDLX shares performed this year? Cardlytics' stock was trading at $9.21 at the beginning of 2024. Since then, CDLX stock has decreased by 58.4% and is now trading at $3.83. View the best growth stocks for 2024 here. How were Cardlytics' earnings last quarter? Cardlytics, Inc. (NASDAQ:CDLX) announced its quarterly earnings data on Wednesday, August, 7th. The company reported ($0.09) earnings per share for the quarter, beating the consensus estimate of ($0.21) by $0.12. The company's quarterly revenue was down 9.2% compared to the same quarter last year. Does Cardlytics have any subsidiaries? Cardlytics subsidiaries include Bridg, DOSH, Cardlytics Services India Private Limited, and Cardlytics UK Limited. When did Cardlytics IPO? Cardlytics (CDLX) raised $76 million in an initial public offering on Friday, February 9th 2018. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan served as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers. Who are Cardlytics' major shareholders? Cardlytics' top institutional shareholders include Creative Planning (0.06%), SG Americas Securities LLC (0.03%) and Shikiar Asset Management Inc. (0.02%). Insiders that own company stock include Clifford Sosin, Karim Saad Temsamani, Lynne Marie Laube, Scott D Grimes, Amit Gupta, Alexis Desieno, Nicholas Hollmeyer Lynton, Andrew Christiansen, John V Balen and Kirk Somers. View institutional ownership trends. How do I buy shares of Cardlytics? Shares of CDLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Cardlytics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cardlytics investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Tesla (TSLA), Intel (INTC) and Rambus (RMBS). Company Calendar Last Earnings8/07/2024Today10/23/2024Next Earnings (Estimated)11/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Computer programming, data processing, & other computer related Sub-IndustryComputer Software Current SymbolNASDAQ:CDLX CUSIPN/A CIK1666071 Webwww.cardlytics.com Phone(888) 798-5802FaxN/AEmployees457Year Founded2008Price Target and Rating Average Stock Price Target$6.92 High Stock Price Target$12.00 Low Stock Price Target$3.50 Potential Upside/Downside+80.6%Consensus RatingReduce Rating Score (0-4)1.86 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($4.42) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-134,700,000.00 Net Margins-50.21% Pretax Margin-50.21% Return on Equity-17.96% Return on Assets-5.97% Debt Debt-to-Equity Ratio1.01 Current Ratio1.77 Quick Ratio1.77 Sales & Book Value Annual Sales$305.42 million Price / Sales0.61 Cash Flow$1.47 per share Price / Cash Flow2.60 Book Value$3.43 per share Price / Book1.12Miscellaneous Outstanding Shares48,783,000Free Float47,647,000Market Cap$186.84 million OptionableOptionable Beta1.67 Social Links 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report This page (NASDAQ:CDLX) was last updated on 10/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonPorter & Company | Sponsored #1 Pre-IPO Opportunity For 2024 [Take Action Now!]According to James, the largest IPO in history could kick off in a matter of weeks. I’m talking about Starl...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredGoldman Sachs’ AI warningAfter warning of last year's historic bank run, weeks in advance... Legendary stock-picker Marc Chaikin jus...Chaikin Analytics | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardlytics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardlytics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.